Potential impact of intervention strategies on COVID-19 transmission in Malawi: a mathematical modelling study

被引:4
作者
Mangal, Tara [1 ]
Whittaker, Charlie [1 ]
Nkhoma, Dominic [2 ]
Ng'ambi, Wingston [2 ]
Watson, Oliver [1 ]
Walker, Patrick [1 ]
Ghani, Azra [1 ]
Revill, Paul [3 ]
Colbourn, Timothy [4 ]
Phillips, Andrew [5 ]
Hallett, Timothy [1 ]
Mfutso-Bengo, Joseph [2 ]
机构
[1] Imperial Coll London, Infect Dis Epidemiol, London, England
[2] Univ Malawi, Coll Med, Lilongwe, Malawi
[3] Univ York, Ctr Hlth Econ, York, N Yorkshire, England
[4] UCL, Inst Global Hlth, London, England
[5] UCL, HIV Epidemiol & Biostat Grp, London, England
基金
英国科研创新办公室; 英国医学研究理事会;
关键词
public health; COVID-19; epidemiology; infection control; CORONAVIRUS DISEASE 2019; AFRICA;
D O I
10.1136/bmjopen-2020-045196
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background COVID-19 mitigation strategies have been challenging to implement in resource-limited settings due to the potential for widespread disruption to social and economic well-being. Here we predict the clinical severity of COVID-19 in Malawi, quantifying the potential impact of intervention strategies and increases in health system capacity. Methods The infection fatality ratios (IFR) were predicted by adjusting reported IFR for China, accounting for demography, the current prevalence of comorbidities and health system capacity. These estimates were input into an age-structured deterministic model, which simulated the epidemic trajectory with non-pharmaceutical interventions and increases in health system capacity. Findings The predicted population-level IFR in Malawi, adjusted for age and comorbidity prevalence, is lower than that estimated for China (0.26%, 95% uncertainty interval (UI) 0.12%-0.69%, compared with 0.60%, 95% CI 0.4% to 1.3% in China); however, the health system constraints increase the predicted IFR to 0.83%, 95% UI 0.49%-1.39%. The interventions implemented in January 2021 could potentially avert 54 400 deaths (95% UI 26 900-97 300) over the course of the epidemic compared with an unmitigated outbreak. Enhanced shielding of people aged >= 60 years could avert 40 200 further deaths (95% UI 25 300-69 700) and halve intensive care unit admissions at the peak of the outbreak. A novel therapeutic agent which reduces mortality by 0.65 and 0.8 for severe and critical cases, respectively, in combination with increasing hospital capacity, could reduce projected mortality to 2.5 deaths per 1000 population (95% UI 1.9-3.6). Conclusion We find the interventions currently used in Malawi are unlikely to effectively prevent SARS-CoV-2 transmission but will have a significant impact on mortality. Increases in health system capacity and the introduction of novel therapeutics are likely to further reduce the projected numbers of deaths.
引用
收藏
页数:10
相关论文
共 49 条
[1]   Potential role of interferons in treating COVID-19 patients [J].
Abdolvahab, Mohadeseh Haji ;
Moradi-kalbolandi, Shima ;
Zarei, Mohammad ;
Bose, Deepanwita ;
Majidzadeh-A, Keivan ;
Farahmand, Leila .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 90
[2]   Estimating excess 1-year mortality associated with the COVID-19 pandemic according to underlying conditions and age: a population-based cohort study [J].
Banerjee, Amitava ;
Pasea, Laura ;
Harris, Steve ;
Gonzalez-Izquierdo, Arturo ;
Torralbo, Ana ;
Shallcross, Laura ;
Noursadeghi, Mahdad ;
Pillay, Deenan ;
Sebire, Neil ;
Holmes, Chris ;
Pagel, Christina ;
Wong, Wai Keong ;
Langenberg, Claudia ;
Williams, Bryan ;
Denaxas, Spiros ;
Hemingway, Harry .
LANCET, 2020, 395 (10238) :1715-1725
[3]   YPredicting the Impact of COVID-19 and the Potential Impact of the Public Health Response on Disease Burden in Uganda [J].
Bell, David ;
Hansen, Kristian Schultz ;
Kiragga, Agnes N. ;
Kambugu, Andrew ;
Kissa, John ;
Mbonye, Anthony K. .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2020, 103 (03) :1191-1197
[4]  
Brazeau N., 2020, Report 34. COVID-19 Infection Fatality Ratio: Estimates from Seroprevalence
[5]  
Campbell A., 2020, The West Australian
[6]   COVID-19 in Malawi: lessons in pandemic preparedness from a tertiary children's hospital [J].
Chaziya, Jessica ;
Freyne, Bridget ;
Lissauer, Samantha ;
Nielsen, Maryke ;
Langton, Josephine ;
O'Hare, Bernadette ;
Molyneux, Liz ;
Moxon, Christopher ;
Tam, Pui-Ying Iroh ;
Hoskyns, Lucy ;
Masanjala, Henderson ;
Ilepere, Sakina ;
Ngwira, Memory ;
Kawaza, Kondwani ;
Mumba, Daniel ;
Chimalizeni, Yamikani ;
Dube, Queen .
ARCHIVES OF DISEASE IN CHILDHOOD, 2021, 106 (03) :238-240
[7]   Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study [J].
Clark, Andrew ;
Jit, Mark ;
Warren-Gash, Charlotte ;
Guthrie, Bruce ;
Wang, Harry H. X. ;
Mercer, Stewart W. ;
Sanderson, Colin ;
McKee, Martin ;
Troeger, Christopher ;
Ong, Kanyin L. ;
Checchi, Francesco ;
Perel, Pablo ;
Joseph, Sarah ;
Gibbs, Hamish P. ;
Banerjee, Amitava ;
Eggo, Rosalind M. .
LANCET GLOBAL HEALTH, 2020, 8 (08) :1003-1017
[8]   Impact assessment of non-pharmaceutical interventions against coronavirus disease 2019 and influenza in Hong Kong: an observational study [J].
Cowling, Benjamin J. ;
Ali, Sheikh Taslim ;
Ng, Tiffany W. Y. ;
Tsang, Tim K. ;
Li, Julian C. M. ;
Fong, Min Whui ;
Liao, Qiuyan ;
Kwan, Mike Y. W. ;
Lee, So Lun ;
Chiu, Susan S. ;
Wu, Joseph T. ;
Wu, Peng ;
Leung, Gabriel M. .
LANCET PUBLIC HEALTH, 2020, 5 (05) :E279-E288
[9]  
Databank, 2020, WORLD BANK GROUP
[10]   Effects of non-pharmaceutical interventions on COVID-19 cases, deaths, and demand for hospital services in the UK: a modelling study [J].
Davies, Nicholas G. ;
Kucharski, Adam J. ;
Eggo, Rosalind M. ;
Gimma, Amy ;
Edmunds, W. John .
LANCET PUBLIC HEALTH, 2020, 5 (07) :E375-E385